Narcolepsy Type 1 & 2 — Cleminorexton

What taking part involves

A screening visit at our Miami office confirms whether a study is a fit. It is provided at no cost and you are under no obligation to continue.

Who may be able to take part

• Adults 18–70
• Diagnosed with NT1 or NT2 per ICSD-3-TR criteria
• ESS score ≥ 12

Final eligibility is determined at your free screening visit.

About this condition

Narcolepsy

Narcolepsy is a chronic neurological disorder in which the brain cannot reliably hold the boundary between sleep and wakefulness. Its central symptom is excessive daytime sleepiness that is not explained by lack of sleep. Nighttime sleep is often broken, and people may have sleep paralysis or vivid dreamlike images as they fall asleep.

It has two forms. Type 1 includes cataplexy — brief muscle weakness triggered by emotion — and follows the loss of hypocretin-producing neurons in the brain. Type 2 brings the same sleepiness without cataplexy. Both are diagnosed with an overnight sleep study followed the next day by a multiple sleep latency test.

Other studies for this condition

If this one is not a fit, another may be. Our coordinators check you against every open protocol, not just the one you applied for.

Registry record

This study is listed in the public registry of clinical studies. The record below is maintained by the study sponsor.

What happens after you apply

1. 1
   Apply Online

   Fill out the short form below — it takes about two minutes and is completely confidential.

2. 2
   Pre-Screening Call

   A bilingual research coordinator calls you within 24 hours to ask brief eligibility questions.

3. 3
   Free Screening Visit

   Visit our Miami office for a no-cost medical evaluation: history, physical exam, and any required tests.

4. 4
   Enroll & Begin

   If eligible, you are officially enrolled and begin the study under direct physician supervision.